Insight Molecular Diagnostics Inc. Common Stock logo

Insight Molecular Diagnostics Inc. Common Stock

IMDX • NASDAQ

Insight Molecular Diagnostics Inc. Common Stock is a in vitro & in vivo diagnostic substances company trading on NASDAQ, led by CEO Joshua Riggs, with a market cap of $114.5M.

CEOJoshua Riggs
Market Cap$114.5M
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Employees49.0
Websiteimdxinc.com

Next Earnings

Upcoming earnings announcement for Insight Molecular Diagnostics Inc. Common Stock

Date
Monday, May 11, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.24
Revenue Estimate
$50.0K

Earnings History

Past 3 earnings reports for Insight Molecular Diagnostics Inc. Common Stock

DatePeriodEPSEPS SurpriseRevenueRev. SurpriseFiling
Mar 26, 2026Q4 2025
-$0.27Est: -$0.24
-12.5%
$1.1MEst: $285.0K
+299.6%SEC10-K
Nov 10, 2025Q3 2025
-$0.34Est: -$0.24
-41.7%
$139.0KEst: $285.0K
-51.2%SEC10-Q
Aug 11, 2025Q2 2025
-$0.30Est: -$0.24
-25.0%
$518.0KEst: $292.0K
+77.4%SEC10-Q
View all filings on SEC EDGAR

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.

Insight Molecular Diagnostics Inc. Common Stock (IMDX) Q1 2026 Earnings - Capbase